MedTrace Logo

Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

NCT02137096 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-06-24

Study results available
· View outcomes & findings →

Summary

This is a pilot study to evaluate the response rates for patients undergoing high dose conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in children, adolescents, and young adults.

Conditions

  • Recurrent Nasopharynx Carcinoma

Interventions

DRUG

Etoposide phosphate

Etoposide is one of three drugs used in the high-dose conditioning phase

DRUG

Carboplatin

Carboplatin is one of the drugs used in the high-dose conditioning phase.

DRUG

Ifosfamide

Ifosfamide is one of the drugs used in the high-dose conditioning phase

PROCEDURE

Autologous Stem Cell Transplantation

Autologous Stem Cell Transplantation follows the high-dose chemotherapy phase of the arm.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • John Fort, MD · University of Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-05-09
Completion
2017-05-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137096 on ClinicalTrials.gov